Company Encyclopedia
View More
name
Xtrack Us Sc Dvd Fd
DES.US
News
View More

Bath & Body Works (NYSE:BBWI) Stock Price Up 3.3% - What's Next?

Bath & Body Works (NYSE:BBWI) shares rose 3.3% to $20.45, with 4.27 million shares traded. Analysts have downgraded the stock, with Barclays setting a target of $18 and Telsey Advisory Group lowering it to $17. The company reported Q3 earnings of $0.35 EPS, missing estimates, and revenue of $1.59 billion. A quarterly dividend of $0.20 was recently paid, yielding 3.9%. Insider purchases were noted, with significant acquisitions by directors. The average analyst rating is "Hold" with a target price of $23.61.

Market Beat·
US
BBWI
+0.10%
Market Beat·
US
BBWI
+0.10%

Bath & Body Works (BBWI) valuation: assessing the stock after ongoing same-store sales weakness and declining EPS trends

Bath & Body Works (BBWI) faces ongoing challenges with weak same-store sales and a projected 5% revenue drop, leading to a year-to-date share price decline of 47.8%. Despite trading at a steep discount, the stock's valuation is debated, with some seeing it as undervalued at $40.73. Key risks include lingering debt from the Victoria’s Secret split and slower international expansion. Investors are advised to consider both the potential rewards and risks.

Simplywall·
US
BBWI
+0.10%
Simplywall·
US
BBWI
+0.10%

Bath & Body Works (BBWI) Gets a Hold from Argus Research

Argus Research's Taylor Conrad maintained a Hold rating on Bath & Body Works, with shares closing at $19.64. Conrad, a 3-star analyst, has a 7.1% average return. Guggenheim's Simeon Siegel also rated it Hold, while Wells Fargo maintained a Buy rating. Conrad covers the Consumer Defensive sector, including stocks like Church & Dwight and Clorox.

Tip Ranks·
US
BBWI
+0.10%
Tip Ranks·
US
BBWI
+0.10%

Bath & Body Works: Undervalued Retail Leader With Strong FCF

Bath & Body Works (BBWI) is highlighted as an undervalued stock with strong free cash flow and a robust direct-to-consumer model. Despite retail challenges, BBWI maintains high margins and aggressive buybacks, shrinking share count. With an IV/P of 1.40, indicating intrinsic value 40% above market price, and an Acquirer’s Multiple of 7.20, BBWI is seen as a compelling opportunity for value investors. The company prioritizes buybacks over dividends, enhancing per-share value. BBWI's stable revenue and pricing power suggest mispricing due to market pessimism.

Talkmarkets·
US
BBWI
+0.10%
Talkmarkets·
US
BBWI
+0.10%

Bath & Body Works (BBWI): Valuation Check After Earnings Miss, Lower Guidance and Insider Buying

Bath & Body Works (BBWI) experienced a challenging quarter with missed earnings and lowered guidance, leading to a significant stock decline. The stock is currently trading at $19.94, with a year-to-date return of -47%. Analysts suggest the stock is undervalued, estimating a fair value of $40.73. The company's valuation is complicated by its 2021 spin-off from L Brands. Investors are advised to consider potential risks, including debt reduction and growth challenges, while exploring other investment opportunities.

Simplywall·
US
BBWI
+0.10%
Simplywall·
US
BBWI
+0.10%
Posts
View More
© 2025 Longbridge｜Disclaimer